FDA Inspection
Hisun Pharmaceutical Hangzhou Co., LtdFDA Inspection 1236569 - Hisun Pharmaceutical Hangzhou Co., Ltd - March 26, 2024
Record Details
This FDA Inspection record concerns Hisun Pharmaceutical Hangzhou Co., Ltd, with an inspection on March 26, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6e6d5609-62b4-4469-8501-7731475cbdb3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1236569
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Hisun Pharmaceutical Hangzhou Co., Ltd
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 29, 2026 | Not classified | Office of Inspections and Investigations | |
| July 20, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 25, 2019 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| March 6, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 27, 2016 | OAI | Center for Veterinary Medicine | Pre-Approval Eval. of Animal Drugs and Food Additives |
Other documents for Hisun Pharmaceutical Hangzhou Co., Ltd
- FDA Inspection 1332580 - 2026-07-29
- FDA Inspection 1148403 - 2021-07-20
- FDA Inspection 1079698 - 2019-01-25
- FDA Inspection 1044032 - 2018-03-06
- FDA Inspection 992914 - 2016-10-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.